rs334000: An Ancestry-Informative Intergenic Marker
The genetic variant rs334000 is a single nucleotide polymorphism located in an intergenic region of the human genome. Rather than acting as a driver of monogenic disease or a direct health-risk factor, it is characterized primarily as an ancestry-informative marker. Large-scale population genetic studies utilize this variant to understand geographic population structure, genetic drift, and continental allele frequency divergence.
What each genotype means
Ancestry-informative marker profile
This genotype is an intergenic marker used primarily in research to help distinguish between different continental population groups. It does not have a known direct impact on health or physical traits, as it is located in a non-coding region of the genome.
The frequency of this genotype varies significantly by ancestry, reflecting its utility as a tool for population differentiation.
Ancestry-informative marker profile
This genotype is an intergenic marker used primarily in research to help distinguish between different continental population groups. It does not have a known direct impact on health or physical traits, as it is located in a non-coding region of the genome.
The frequency of this genotype varies significantly by ancestry, reflecting its utility as a tool for population differentiation.
Ancestry-informative marker profile
This genotype is an intergenic marker used primarily in research to help distinguish between different continental population groups. It does not have a known direct impact on health or physical traits, as it is located in a non-coding region of the genome.
The frequency of this genotype varies significantly by ancestry, reflecting its utility as a tool for population differentiation.
Genomic Context and Biological Location
The single nucleotide polymorphism designated as rs334000 represents a single base-pair variation situated within an intergenic region of the genome. Intergenic DNA refers to stretches of sequence located between functional genes that do not code for protein sequences. Because it does not disrupt an open reading frame, an essential splice junction, or a characterized protein-coding domain, rs334000 behaves predominantly as a neutral genomic marker. Variants positioned in intergenic desert regions generally avoid severe evolutionary purifying selection, enabling their allele frequencies to drift naturally over millennia as ancestral human populations migrated and expanded across different geographic continents.
Role as an Ancestry-Informative Marker (AIM)
In human genomics, ancestry-informative markers (AIMs) are single nucleotide polymorphisms that display marked differences in allele frequency across distinct geographic populations. Scientific literature establishes rs334000 as a valuable tool for continental ancestry differentiation panels. Instead of causing functional changes in cellular biology, the variant serves as a reliable statistical benchmark in population genetics. Researchers leverage panels of AIMs like rs334000 to infer deep demographic history, trace continental origins, and correct for hidden population stratification in large-scale genome-wide association studies (GWAS) to prevent false-positive associations.
Scientific Evidence and Phenotypic Impact
The current scientific evidence supporting rs334000 as a direct phenotypic or clinical determinant is functionally minimal, whereas its evidence as an ancestry discriminator is moderate and well-replicated. Major genomic repositories—such as ClinVar, dbSNP, and the NHGRI-EBI GWAS Catalog—do not associate rs334000 with monogenic pathology, elevated disease susceptibility, or adverse pharmacological reactions. Any observed correlations between this locus and complex physiological traits are frequently artifacts of population structure rather than true biological causation. Consequently, the variant is best understood as a benign, non-coding marker of demographic history rather than a medical risk predictor.
Global Allele Frequencies Across Populations
The defining attribute of rs334000 is its pronounced variation in frequency across global human groups. Reference datasets, including the 1000 Genomes Project and gnomAD, demonstrate notable allele frequency disparities across continental ancestries. For example, the minor allele frequency reaches approximately 0.45 in populations of European ancestry, whereas it drops sharply to around 0.08 in East Asian populations. These sharp continental differences are characteristic of loci shaped by genetic drift following ancestral divergence, reinforcing the suitability of rs334000 for inclusion in multi-locus continental assignment algorithms.
What You Can and Cannot Do With This Information
Encountering rs334000 on a personal genotyping report simply illustrates a non-pathogenic snapshot of your ancestral DNA. Because this variant does not alter cellular function or indicate disease predisposition, you cannot use this result to guide medical choices, alter dietary plans, or diagnose health conditions. Similarly, no individual can deduce their full genealogical background from a single marker, as accurate ancestry modeling requires analyzing hundreds to thousands of markers simultaneously. If you have concerns about your family medical history or complex health risks, you should consult a licensed genetic counselor or physician rather than drawing conclusions from neutral intergenic variants.
How common is this variant?
The minor allele frequency for rs334000 varies dramatically across geographic groups, occurring at approximately 0.45 in European populations and roughly 0.08 in East Asian populations according to 1000 Genomes data.
Frequently asked questions
Does having a specific genotype at rs334000 cause any health conditions?
No. The rs334000 variant is an intergenic marker located outside of protein-coding genes and is considered benign. It is not listed as a pathogenic variant in clinical repositories such as ClinVar or PharmGKB.
Can rs334000 alone reveal my exact heritage or country of origin?
No. While rs334000 shows significant allele frequency differences between continental groups, no single genetic marker can determine your ancestry. Reliable ancestry estimation requires evaluating many hundreds or thousands of ancestry-informative markers in aggregate.
Why is rs334000 included in commercial genetic testing arrays?
Commercial genotyping arrays frequently include markers like rs334000 to assist laboratory quality control and statistical ancestry inference. Tracking these markers helps research algorithms account for broad demographic backgrounds and detect population stratification.
Does rs334000 affect how my body metabolizes prescription medications?
There is no scientific evidence linking rs334000 to drug metabolism, transport, or adverse pharmacogenetic reactions. Any questions regarding prescription medications or individual dosing should always be discussed directly with your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs334000?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the 8q24 region is associated with increased prostate cancer risk in men of West African and Puerto Rican ancestry.
This variant is linked to clinical outcomes and drug response in heart failure patients.
A robustly associated genetic locus linked to habitual short sleep duration in large-scale multi-ancestry GWAS cohorts.
A genome-wide significant risk locus identified in cross-biobank analyses for habitual short sleep duration.
This variant is a well-replicated genome-wide significant locus associated with habitual sleep duration, including both short and long sleep phenotypes.
This variant in the CLOCK gene is associated with variations in circadian rhythm, chrononutrition, and metabolic parameters in adolescents.